Anson Funds Management LP Adamis Pharmaceuticals Corp Transaction History

Anson Funds Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$0.33 - $0.66 $994,307 - $1.99 Million	-3,013,054 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.33 - $0.89 $994,307 - $2.68 Million	3,013,054 New	3,013,054 $2.74 Million
Q4 2019 Feb 14, 2020	SELL	$0.51 - $1.26 $736,734 - $1.82 Million	-1,444,578 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.7 - $1.46 $1.01 Million - $2.11 Million	1,444,578 New	1,444,578 $1.02 Million

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

Stay updated on Anson Funds Management LP with notifications on news.